Mounjaro®
Starting from £179.99/mo
Start journey Learn moreBloating is one of the most commonly reported experiences in the first weeks on Wegovy. Semaglutide slows the rate at which food leaves your stomach, and that change in gastric emptying can leave you feeling full, gassy and uncomfortable — particularly after eating. For most people, the bloating is manageable and settles as the body adjusts. Wegovy is a prescription-only medicine, and a prescriber will consider your full picture before and during treatment, including how side effects are affecting you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide works by activating GLP-1 receptors in the gut and brain, which reduces appetite and slows gastric emptying. That second effect (food moving more slowly from the stomach into the small intestine) is exactly what's behind the bloating. Gas builds up, the stomach feels distended, and you may notice belching or flatulence alongside the fullness. None of this is unusual; it reflects the medicine doing what it's designed to do.
The effect is usually most pronounced right after a dose increase, when the body is adapting to a higher level of semaglutide. The semaglutide treatment overview explains how the dose-escalation schedule is designed partly to give your digestive system time to adjust before the next step up. Most people find the bloating peaks in the first few days after a new pen, then softens.
A useful checking habit: note roughly how long after eating the discomfort starts. If it consistently appears within 30 to 60 minutes of a meal and passes over an hour or two, that's the gastric-emptying pattern. If it's arriving unprovoked and lasting many hours, tell your prescriber at your next review.
Small, frequent meals are consistently better tolerated than large ones while you're on Wegovy. Because your stomach empties more slowly, a big plate overwhelms a gut that's already working at reduced speed. Protein-rich foods and cooked vegetables tend to sit better than large amounts of raw brassicas, pulses or carbonated drinks, all of which add gas load on top of an already slower system.
Eating speed matters too. Sitting down and chewing properly sounds obvious, but many people find it makes a real difference when they're on a GLP-1 medicine. Alcohol can worsen reflux and nausea for some people on semaglutide, which compounds any bloating. If you're finding the bloating severe, that persistent full feeling on Wegovy is worth reading alongside this, they often go together and some of the same strategies help.
Over-the-counter remedies for bloating and gas (simethicone-based products, peppermint capsules) are used by some patients, but check with your prescriber before adding anything regularly, as timing relative to Wegovy can matter.
The NHS patient information on semaglutide lists nausea, vomiting, constipation, diarrhoea and stomach pain as common effects, usually mild to moderate. Bloating fits within that group. What falls outside it is a different matter.
Severe, persistent stomach pain (particularly pain that radiates towards the back, with or without vomiting) is a signal to stop waiting and get assessed. In January 2026 the MHRA issued a Drug Safety Update specifically for GLP-1 medicines, highlighting acute pancreatitis as an infrequent but serious risk; the key symptom is that deep, persistent abdominal pain that doesn't pass. This is genuinely rare, but it's the reason the guidance says don't sit on it. You can report unexpected or serious side effects at the MHRA's Yellow Card scheme.
Gallbladder symptoms (sharp pain in the upper right abdomen, sometimes after eating fatty food) are another reason to contact a doctor rather than manage things at home. Rapid weight loss of any cause can increase gallstone risk, and GLP-1 medicines are no exception.
For everything milder, the practical question is whether the bloating is disrupting your ability to eat adequately. If you're skipping meals entirely because of discomfort, that's worth raising with your prescriber at the next clinical review, not because it's dangerous, but because there are ways to adjust the approach.
Bloating on its own rarely changes the clinical direction of treatment. What it sometimes signals is that the current dose is ahead of where your digestive system is comfortable, or that eating habits need some adjustment for the new pace of digestion. Neither of those is a reason to stop, they're calibration points.
If you're wondering how Wegovy compares in terms of tolerability with other options, the weight-loss treatment overview covers the landscape at a higher level. And if you're on Wegovy through a private route and your circumstances have changed, the refill process includes a clinical re-check at every stage, giving you a natural point to raise anything that's been bothering you.
Some people also notice other physical changes early in treatment, feeling warmer than usual or feeling cold have both been reported by people starting semaglutide, though these are less directly linked to the gut mechanism than bloating is. The Wegovy treatment guide brings the full side-effect and adjustment picture together in one place.
If you haven't yet started treatment and are weighing up whether the side-effect profile feels manageable, our prescribers are the right people to talk it through with. A free consultation with nume means your answers are read the same day by a real clinician, not processed by software. Start your free consultation and get a considered clinical view on whether Wegovy is right for you.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.